메뉴 건너뛰기




Volumn 20, Issue 2, 2009, Pages 390-396

Development of protein-binding bifunctional linkers for a new generation of dual-acting prodrugs

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; CARBOXYL GROUP; CATHEPSIN B; CYSTEINE; DOXORUBICIN; MALEIMIDE; PACLITAXEL; PRODRUG; THIOL GROUP;

EID: 62549144354     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800429q     Document Type: Article
Times cited : (51)

References (30)
  • 1
    • 34447520330 scopus 로고    scopus 로고
    • Anticancer carrier-linked prodrugs in clinical trials
    • Kratz, F., Abu Ajaj, K., and Warnecke, A. (2007) Anticancer carrier-linked prodrugs in clinical trials. Expert Opin. Invest. Drugs 16, 1037-1058.
    • (2007) Expert Opin. Invest. Drugs , vol.16 , pp. 1037-1058
    • Kratz, F.1    Abu Ajaj, K.2    Warnecke, A.3
  • 3
    • 0037068501 scopus 로고    scopus 로고
    • Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: Inhibition of aggregation by methoxytriethyleneglycol chains
    • King, H. D., Dubowchik, G. M., Mastalerz, H., Willner, D., Hofstead, S. J., Firestone, R. A., Lasch, S. J., and Trail, P. A. (2002) Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains. J. Med. Chem. 45, 4336-4343.
    • (2002) J. Med. Chem , vol.45 , pp. 4336-4343
    • King, H.D.1    Dubowchik, G.M.2    Mastalerz, H.3    Willner, D.4    Hofstead, S.J.5    Firestone, R.A.6    Lasch, S.J.7    Trail, P.A.8
  • 4
    • 0036579776 scopus 로고    scopus 로고
    • Paclitaxel delivery systems: The use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs
    • Sugahara, S., Kajiki, M., Kuriyama, H., and Kobayashi, T. R. (2002) Paclitaxel delivery systems: the use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs. Biol Pharm. Bull. 25, 632-641.
    • (2002) Biol Pharm. Bull , vol.25 , pp. 632-641
    • Sugahara, S.1    Kajiki, M.2    Kuriyama, H.3    Kobayashi, T.R.4
  • 6
    • 0029617286 scopus 로고
    • Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro
    • Akutsu, M., Kano, Y., Tsunoda, S., Suzuki, K., Yazawa, Y., and Miura, Y. (1995) Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro. Eur. J. Cancer 31A, 2341-2346.
    • (1995) Eur. J. Cancer , vol.31 A , pp. 2341-2346
    • Akutsu, M.1    Kano, Y.2    Tsunoda, S.3    Suzuki, K.4    Yazawa, Y.5    Miura, Y.6
  • 7
    • 0027753079 scopus 로고
    • Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assay
    • Koechli, O. R., Sevin, B. U., Perras, J. P., Chou, T. C., Angioli, R., Steren, A., Untch, M., and Averette, H. E. (1993) Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assay. Breast Cancer Res. Treat. 28, 21-27.
    • (1993) Breast Cancer Res. Treat , vol.28 , pp. 21-27
    • Koechli, O.R.1    Sevin, B.U.2    Perras, J.P.3    Chou, T.C.4    Angioli, R.5    Steren, A.6    Untch, M.7    Averette, H.E.8
  • 8
    • 33646872893 scopus 로고    scopus 로고
    • A phase I study of paclitaxel/ doxorubicin/ thalidomide in patients with androgen- independent prostate cancer
    • Amato, R. J., and Sarao, H. (2006) A phase I study of paclitaxel/ doxorubicin/ thalidomide in patients with androgen- independent prostate cancer. Clin. Genitourin Cancer 4, 281-286.
    • (2006) Clin. Genitourin Cancer , vol.4 , pp. 281-286
    • Amato, R.J.1    Sarao, H.2
  • 9
    • 2142708274 scopus 로고    scopus 로고
    • Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer
    • Zielinski, C. C. (2003) Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer. Oncology (Williston Park) 17, 36-40.
    • (2003) Oncology (Williston Park) , vol.17 , pp. 36-40
    • Zielinski, C.C.1
  • 11
    • 33645757580 scopus 로고    scopus 로고
    • Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: A translational research experience
    • Passardi, A., Massa, I., Zoli, W., Gianni, L., Milandri, C., Zumaglini, F., Nanni, O., Maltoni, R., Frassineti, G. L., and Amadori, D. (2006) Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience. BMC Cancer 6, 76.
    • (2006) BMC Cancer , vol.6 , pp. 76
    • Passardi, A.1    Massa, I.2    Zoli, W.3    Gianni, L.4    Milandri, C.5    Zumaglini, F.6    Nanni, O.7    Maltoni, R.8    Frassineti, G.L.9    Amadori, D.10
  • 14
    • 0019453510 scopus 로고
    • A novel connector linkage applicable in prodrug design
    • Carl, P. L., Chakravarty, P. K., and Katzenellenbogen, J. A. (1981) A novel connector linkage applicable in prodrug design. J. Med. Chem. 24, 479-480.
    • (1981) J. Med. Chem , vol.24 , pp. 479-480
    • Carl, P.L.1    Chakravarty, P.K.2    Katzenellenbogen, J.A.3
  • 15
    • 34347354414 scopus 로고    scopus 로고
    • Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: Synthesis and antitumor efficacy
    • Schmid, B., Chung, D. E., Warnecke, A., Fichtner, I., and Kratz, F. (2007) Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy. Bioconjugate Chem. 18, 702-716.
    • (2007) Bioconjugate Chem , vol.18 , pp. 702-716
    • Schmid, B.1    Chung, D.E.2    Warnecke, A.3    Fichtner, I.4    Kratz, F.5
  • 16
    • 0036074253 scopus 로고    scopus 로고
    • Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: Model studies of enzymatic drug release and antigen-specific in vitro anticancer activity
    • Dubowchik, G. M., Firestone, R. A., Padilla, L., Willner, D., Hofstead, S. J., Mosure, K., Knipe, J. O., Lasch, S. J., and Trail, P. A. (2002) Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activity. Bioconjugate Chem. 13, 855-869.
    • (2002) Bioconjugate Chem , vol.13 , pp. 855-869
    • Dubowchik, G.M.1    Firestone, R.A.2    Padilla, L.3    Willner, D.4    Hofstead, S.J.5    Mosure, K.6    Knipe, J.O.7    Lasch, S.J.8    Trail, P.A.9
  • 17
    • 0342314489 scopus 로고    scopus 로고
    • A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy
    • Kratz, F., Mueller-Driver, R., Hofmann, I., Drevs, J., and Unger, C. (2000) A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy. J. Med. Chem. 43, 1253-1256.
    • (2000) J. Med. Chem , vol.43 , pp. 1253-1256
    • Kratz, F.1    Mueller-Driver, R.2    Hofmann, I.3    Drevs, J.4    Unger, C.5
  • 18
    • 0037028050 scopus 로고    scopus 로고
    • Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives: Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound
    • Kratz, F., Warnecke, A., Scheuermann, K., Stockmar, C., Schwab, J., Lazar, P., Druckes, P., Esser, N., Drevs, J., Rognan, D., Bissantz, C., Hinderung, C., Folkers, G., Fichtner, I., and Unger, C. (2002) Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives: improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. J. Med. Chem. 45, 5523-5533.
    • (2002) J. Med. Chem , vol.45 , pp. 5523-5533
    • Kratz, F.1    Warnecke, A.2    Scheuermann, K.3    Stockmar, C.4    Schwab, J.5    Lazar, P.6    Druckes, P.7    Esser, N.8    Drevs, J.9    Rognan, D.10    Bissantz, C.11    Hinderung, C.12    Folkers, G.13    Fichtner, I.14    Unger, C.15
  • 19
    • 0042173127 scopus 로고    scopus 로고
    • A new approach for the treatment of malignant melanoma: Enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2
    • Mansour, A. M., Drevs, J., Esser, N., Hamada, F. M., Badary, O. A., Unger, C., Fichtner, I., and Kratz, F. (2003) A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2. Cancer Res. 63, 4062-4066.
    • (2003) Cancer Res , vol.63 , pp. 4062-4066
    • Mansour, A.M.1    Drevs, J.2    Esser, N.3    Hamada, F.M.4    Badary, O.A.5    Unger, C.6    Fichtner, I.7    Kratz, F.8
  • 20
    • 0032421248 scopus 로고    scopus 로고
    • Serum proteins as drug carriers of anticancer agents: A review
    • Kratz, F., and Beyer, U. (1998) Serum proteins as drug carriers of anticancer agents: a review. Drug Delivery 5, 281-299.
    • (1998) Drug Delivery , vol.5 , pp. 281-299
    • Kratz, F.1    Beyer, U.2
  • 21
    • 0034000453 scopus 로고    scopus 로고
    • Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review
    • Maeda, H., Wu, J., Sawa, T., Matsumura, Y., and Hori, K. (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Release 65, 271-284.
    • (2000) J. Controlled Release , vol.65 , pp. 271-284
    • Maeda, H.1    Wu, J.2    Sawa, T.3    Matsumura, Y.4    Hori, K.5
  • 22
    • 34249980937 scopus 로고    scopus 로고
    • DOXO-EMCH (INNO-206): The first albumin-binding prodrug of doxorubicin to enter clinical trials
    • Kratz, F. (2007) DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials. Expert Opin. Investig. Drugs 16, 855-66.
    • (2007) Expert Opin. Investig. Drugs , vol.16 , pp. 855-866
    • Kratz, F.1
  • 23
    • 27644436770 scopus 로고    scopus 로고
    • Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen
    • Kratz, F., Mansour, A., Soltau, J., Warnecke, A., Fichtner, I., Unger, C., and Drevs, J. (2005) Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen. Arch. Pharm. (Weinheim) 338, 462-412.
    • (2005) Arch. Pharm. (Weinheim) , vol.338 , pp. 462-412
    • Kratz, F.1    Mansour, A.2    Soltau, J.3    Warnecke, A.4    Fichtner, I.5    Unger, C.6    Drevs, J.7
  • 24
    • 33747339731 scopus 로고    scopus 로고
    • Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA)
    • Chung, D. E., and Kratz, F. (2006) Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA). Bioorg. Med. Chem. Lett. 16, 5157-5163.
    • (2006) Bioorg. Med. Chem. Lett , vol.16 , pp. 5157-5163
    • Chung, D.E.1    Kratz, F.2
  • 25
    • 38749154289 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP)
    • Graeser, R., Chung, D. E., Esser, N., Moor, S., Schachtele, C., Unger, C., and Kratz, F. (2008) Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP). Int. J. Cancer 122, 1145-1154.
    • (2008) Int. J. Cancer , vol.122 , pp. 1145-1154
    • Graeser, R.1    Chung, D.E.2    Esser, N.3    Moor, S.4    Schachtele, C.5    Unger, C.6    Kratz, F.7
  • 26
    • 47949115836 scopus 로고    scopus 로고
    • Targeted drug delivery by in vivo coupling to endogenous albumin: An albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis
    • Fiehn, C., Kratz, F., Sass, G., Muller-Ladner, U., and Neumann, E. (2008) Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Ann. Rheum. Dis. 67, 1188-1191.
    • (2008) Ann. Rheum. Dis , vol.67 , pp. 1188-1191
    • Fiehn, C.1    Kratz, F.2    Sass, G.3    Muller-Ladner, U.4    Neumann, E.5
  • 27
    • 34548067350 scopus 로고    scopus 로고
    • Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B
    • Warnecke, A., Fichtner, I., Sass, G., and Kratz, F. (2007) Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B. Arch. Pharm. (Weinheim) 340, 389-395.
    • (2007) Arch. Pharm. (Weinheim) , vol.340 , pp. 389-395
    • Warnecke, A.1    Fichtner, I.2    Sass, G.3    Kratz, F.4
  • 28
    • 0035896201 scopus 로고    scopus 로고
    • Acid-labile protecting groups for the synthesis of lipidated peptides
    • Kadereit, D., Deck, P., Heinemann, I., and Waldmann, H. (2001) Acid-labile protecting groups for the synthesis of lipidated peptides. Chem. Eur. J. 7, 1184-1193.
    • (2001) Chem. Eur. J , vol.7 , pp. 1184-1193
    • Kadereit, D.1    Deck, P.2    Heinemann, I.3    Waldmann, H.4
  • 29
    • 0030792535 scopus 로고    scopus 로고
    • Monomethoxytrityl (MMT) as a versatile amino protecting group for complex prodrugs of anticancer compounds sensitive to strong acids, bases and nucleophiles
    • Dubowchik, G. M., and Radia, S. (1997) Monomethoxytrityl (MMT) as a versatile amino protecting group for complex prodrugs of anticancer compounds sensitive to strong acids, bases and nucleophiles. Tetrahedron Lett. 38, 5257-5260.
    • (1997) Tetrahedron Lett , vol.38 , pp. 5257-5260
    • Dubowchik, G.M.1    Radia, S.2
  • 30
    • 58849118375 scopus 로고    scopus 로고
    • Abu Ajaj, K., and Kratz, F. (2009) Development of dual-acting prodrugs for circumventing multidrug resistance in breast cancer. Bioorg. Med. Chem. Lett., online, DOI: 10.1016/j.bmcl.2008.11.063.
    • Abu Ajaj, K., and Kratz, F. (2009) Development of dual-acting prodrugs for circumventing multidrug resistance in breast cancer. Bioorg. Med. Chem. Lett., online, DOI: 10.1016/j.bmcl.2008.11.063.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.